Since 2015, PlaMatrix has been committed to the development of a unique expertise for the design and manufacturing of high-quality medical devices, intended for cells therapies and for the preparation of autologous platelet-rich plasma (PRP) from the patient’s own blood for the purpose of using the platelets, cells and essential proteins for indications in various medical disciplines such as dermatology, aesthetics, orthopedics, sports medicine, wound care, dental, veterinary and more. PlaMatrix unique products can be applied either on a standalone basis or as complementary along with other biologics and therapeutic methods.
In the past years, our products have been sold to more than 30 countries in Europe, North America, the Middle East, Southeast Asia, North Africa, and more than 500,000 patients have been treated with PlaMatrix products.